Since the HCC patients with dominant Gal-1– LC3+ TAMs had the worst OS and PFS in our cohort, serum Gal-1 levels may be a helpful surrogate to determine the dominant phenotypes of TAMs and further be an adverse prognostic indicator to classify patients at high risk. Here, MAP1LC3A is linked to hepatocellular carcinoma.